Login / Signup

Imino- and Azasugar Protonation Inside Human Acid β-Glucosidase, the Enzyme that is Defective in Gaucher Disease.

Camilla MatassiniJulia WarrenBo WangAndrea GotiFrancesca CardonaAmelia MorroneMikael Bols
Published in: Angewandte Chemie (International ed. in English) (2020)
Gaucher disease is caused by mutations in human acid β-glucosidase or glucocerebrosidase (GCase), the enzyme responsible for hydrolysis of glucosyl ceramide in the lysosomes. Imino- and azasugars such as 1-deoxynojirimycin and isofagomine are strong inhibitors of the enzyme and are of interest in pharmacological chaperone therapy of the disease. Despite several crystal structures of the enzyme with the imino- and azasugars bound in the active site having been resolved, the actual acid-base chemistry of the binding is not known. In this study we show, using photoinduced electron transfer (PET), that 1-deoxynojirimycin and isofagomine derivatives are protonated by human acid β-glucosidase when bound, even if they are completely unprotonated outside the enzyme. While isofagomine derivative protonation to some degree was foreshadowed by earlier crystal structures, 1-deoxynojirimycin derivatives were not believed to act as basic amines in the enzyme.
Keyphrases
  • endothelial cells
  • electron transfer
  • induced pluripotent stem cells
  • molecular docking
  • pluripotent stem cells
  • computed tomography
  • oxidative stress
  • stem cells
  • bone marrow
  • cell therapy
  • smoking cessation